SYNOPSIS HL-A antigens were determined in 159 myasthenic patients, 112 of whom were females and 47 males. Fifty-seven patients were thymectomized. The relationship between 23 different HL-A antigens and myasthenia gravis (MG) with reference to sex, age at onset, clinical course of MG, thymus histology, and auxiliary diseases of the patients, as well as the significance of these antigens to 245 relatives of myasthenics, were analysed. The frequencies of HL-A1 and HL-A8 were highly significantly higher in myasthenic patients than in normal Finnish controls. The increase of HL-A1 is secondary and due to a strong linkage disequilibrium between HL-A8 and HL-Al. HL-A8 appeared most often in females with onset of MG before the age of 35 years, and inpatients with thymus hyperplasia. No significant HL-A deviations were found in males or in females with later onset of disease. In seven thymoma patients the occurrence of W1O antigen was almost significantly increased.
In 1960 Simpson, Strauss et al., and Nastuk et al. (1959) , independently suggested that myasthenia gravis (MG) might be some kind of autoimmune disease. This is well accepted today, even though the basic mechanism of the immunological dysfunction remains unresolved.
Many kinds of humoral autoantibodies have been found in myasthenic patients but their pathogenetic significance is still obscure. Several findings support the concept of alterations in the cell-mediated immunity, the well-known thymus pathology in about 80% of patients, the frequent presence of muscle lymphorrhages, the increased cytotoxicity of myasthenic lymphocytes both in vivo (Namba et al., 1969a, b) and in vitro (Armstrong et al., 1973) , and the migration inhibition of myasthenic lymphocytes in the presence of muscle antigen (Alpert et al., 1972; Kott et al., 1973) and thymus antigen (Vejjajiva et al., 1974) .
The increased occurrence of other autoimmune disorders in patients with MG has also been confirmed by many authors (Simpson, 1960; Oosterhuis et al., 1964; Oosterhuis and de Haas, 1968; Whittingham et al., 1970) .
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The familial incidence of MG is higher than would be expected by chance: calculated by Namba et al. (1971) , 3.4%O of 1875 patients are related as compared with approximately 0.01% in the population (Kurland and Alter, 1961) . The pattern of inheritance is not clear and seems to be multifactorial.
We have sought evidence for the possible influence of inheritance by investigating one genetic polymorphism of tissue cells, the socalled human leucocyte antigens, or HL-A. The frequency of HL-A8 was found to be significantly increased in 38 unselected myasthenics, especially in women with onset of MG below the age of 30 years (Pirskanen et al., 1972) . This finding has been confirmed by many others (Behan et al., 1973; Safwenberg et al., 1973; Dick et al., 1974; Feltkamp et al., 1974; Fritze et al., 1974) . Fritze et al. (1974) found in addition that HL-A3 was significantly increased in male patients and was also linked to thymoma. Feltkamp et al. (1974) did not confirm these findings but observed HL-A2 to be increased in patients with thymoma or with late onset of the disease. Both teams reported that HL-A8 was significantly increased in females with earlier (Oosterhuis, 1964) Because of a possibility of overestimation of the association between an antigen and the disease, the resultant P-values were multiplied by 23, the number of specificities being tested ('corrected-P-values'). P-value < 0.001 will be described as 'highly significant', < 0.01 as 'significant', and <0.05 as 'almost significant'. The corresponding gene frequencies were calculated in two ways (see (Bodmer and Payne, 1965) . In other words, fij is the observed frequency of a given HL-A haplotype and g1 x gj gives the expected value of that haplotype frequency if all the antigens were linked together by chance.
RESULTS
In Table 3 the HL-A phenotype frequencies of 159 myasthenics are compared with those of 326 normal Finnish controls In the random Finnish population HL-A7 is the most common and W15 the second most common antigen of the SD II group. The HL-A8 frequency in myasthenics is 2.73-fold as compared with controls. If non-HL-A8 antigens were Table 4 presents the phenotype frequencies in the different age and sex groups. We also determined the frequencies in the group contracting the disease before the age of 16 years, but these did not differ from those of the group with onset at below the age of 35 years. The age of 35 years was selected for the division of patients according to age because of all groupings at five year intervals this revealed the best discrimination for HL-A8 frequencies.
The only significantly increased frequencies are those of HL-A1 and 8 in the younger female group. The decrease of WI 5 in the same group is secondary and due to the increase of HL-A8.
In males and in the older age group of females no significant deviations from normal controls were found when only the corrected P-values are considered. Table 5 compares the occurrence of HL-A antigens in the different clinical groups. The figures are given in numbers of cases because of the small size of some patient groups.
In the occular group (I) there are no significant deviations from the controls. In the milder MG group (IIA) HL-A8 is found in 41.4,'; in the more severe form of the disease (IIB-IV) in 37.22%; and in patients who improved with time (IIB-IV changes to IIA or to A) (the majority after thymectomy) in 72.3%. All these increases are significant. In the IIB-IV group the decrease of HL-A7 is almost significant. A comparison of the frequencies in myasthenics and controls (Table 7b) shows an increase of haplotype 1.8 (highly significant), 28.8 (significant), and 9.W1O (almost significant), and an almost significant decrease of haplotype 2.W1O in MG patients. When only corrected P values are taken into account, the increase of the gene determining HL-A1 in myasthenics is almost significant and that one determining HL-A8 highly significant. If uncorrected P-values are (Bodmer, 1972 The incidence of autoimmune, allergic, or endocrine disorders is even lower in HL-A8 positive than HL-A8 negative relatives. Table 10 summarizes the frequency of HL-A8 in these 245 healthy and unhealthy relatives of myasthenics.
With regard to segregation of any of these diseases with HL-A antigens, these family pedigree studies turned out to be unproductive, even though in some families some atopic tendency seems to segregate with HL-A8. Table 11 presents certain associated diseases in 159 myasthenics and their relation to HL-A8. The significances are calculated by comparing the observed frequency of HL-A8 in a group of n myasthenics having a given additional disorder with the frequency of HL-A8 in the (159-n) myasthenics. The frequency of rheumatoid arthritis (criteria according to American Rheumatoid Association) was 3.8%, systemic lupus erythematosus 1,9%, thyroid hormone disorders 9,400, and 'neurovegetative' symptoms-for example, general asthenia, acrocyanosis, cardiac arrhythmias, abnormal sweating, and chill, etc.
23.9%. These are all increased compared with a
Finnish control population. The frequencies of HL-A8 in these patients do not differ from the frequencies in the myasthenics without the said disorders with the exception of patients with 'neurovegetative' symptoms in whom HL-A8 is 'almost significantly' (P <0.05) increased. It is also interesting to find that HL-A8 is almost In our patients, HL-A8 is inherited almost significantly (P <0.05) more often from the father (19 subjects) than from the mother (11 subjects). This could be connected with the combined evidence by various authors showing that, in familial cases, myasthenia appears more often in father and child than in mother and child. The same inheritance was not found by Behan et al. (1973) . In their study of eight cases HL-A8 was inherited four times each from father and from mother.
We did not find any significant increase of HL-A2 or 3 in thymoma patients, contrary to Feltkamp et al. (1974) and Fritze et al. (1974) . Instead, we found WIO to be almost significantly increased in thymoma patients, but our thymoma material is too small for definite conclusions. In our study HL-A8 seems to be of no importance to 245 relatives of 106 myasthenics in respect of an increased risk of an autoimmune or endocrine disorder. Even in familial cases, HL-A8 is not always found, indicating that it may be only one of the many factors that are required for the outbreak of myasthenia gravis or of another immunological disorder.
Myasthenics with no other additional symptoms have a high incidence of HL-A8 (65.6% HL-A8+). We can assume that this is the 'basic figure' indicating the effect of HL-A8 on the penetrance of myasthenia. Both the socalled collagen diseases and thyroid disorders occur in myasthenic patients more often than in the whole population. In this study the incidence of HL-A8 in these patients is a little lower than the 'basic figure'. Perhaps these disorders facilitate penetrance of myasthenia gravis. The joint influence of all these disease susceptibility factors may render the presence of the HL-A8-associated susceptibility factors superfluous. In any case, the number of examples of each disorder in the present study is too small to justify conclusions of their effect on the frequency of HL-A8. It is interesting to note that myasthenics with different neurovegetative symptoms (most often acrocyanosis and general asthenia) have HL-A8 more often than myasthenics without those symptoms.
HL-A8 has been demonstrated in other studies to be associated with several other diseases featuring lymphocytic infiltration of a target organ and/or the thymus: this is the case with chronic active autoimmune hepatitis (MacKay and Morris, 1972) , dermatitis herpetiformis (Gebhard et al., 1973) , Graves' disease (Grumet et al., 1973) , idiopathic Addison's disease , some forms of systemic lupus erythematosus (Grumet et al., 1971) , juvenile diabetes , coeiiac disease (Stokes et al., 1972) , and perhaps with childhood asthma (Thorsby et al., 1971 ). HL-A8 or an associated immune response (IR) gene might thus be one of the factors affecting endocrine autoimmunity. We have also looked for some specific LD (IR?) gene with a strong positive disequilibrium linkage with HL-A8 that would better explain the very marked association between myasthenia and HL-A8.
One specific LD gene (LD-8a) was found to be linked strongly to HL-A8 but only a little more often in myasthenics than in control persons. A specifically myasthenia-associated LD gene as determined by MLC technique was not found (Kaakinen et al., in press ). Thus a possible myasthenia-susceptibility gene(s) may be situated closer to the FOUR locus than to the LD-l locus. The clinical, serological, and familial overlap of certain autoimmune diseases suggests that they may have a common genetic base and that some extrinsic factor (possibly one causing somatic mutation in lymphoid stem cells) is needed to bring forth a particular autoimmune disease. In myasthenia gravis these mutated immunocytes or some product of theirs might then be directed against substances (for example, cholinacetylase?) in the synaptic area or against the neurotransmitter receptor site. This need not be a true antigen-antibody reaction. It is worth mentioning that HL-A8 is found in the plasma membrane of all cells, also of nerve and muscle cells, and that in MG morphological changes have been shown in the membranes of both these cells. HL-A8 may also represent a genetically determined weak point in either of these membranes.
Histocompatibility antigens have given neither an aetiological nor a pathogenetic explanation but have added to the evidence for inherited susceptibility to myasthenia gravis. The exact relationship between them remains to be clarified.
